Amgen Inc (BUE:AMGN)
ARS 10400 250 (2.46%) Market Cap: 151.64 Til Enterprise Value: 203.40 Til PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 57/100

Amgen Inc at Citi BioPharma Conference (Virtual) Transcript

Sep 10, 2020 / 06:25PM GMT
Release Date Price: ARS6200 (-0.06%)
Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst

Great. Good afternoon, everyone. And I think it's still good morning at Amgen as well. So great. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the [biotech] at Citi.

So I'm happy to have Amgen management team today with us. We have Murdo Gordon, EVP and Global -- EVP and Head of Global Commercial Operations at Amgen; Peter Griffith, the CFO of the company; Arvind Sood, the Head IR of the company. Thank you, Murdo, Peter and Arvind, for joining us today.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Thanks, Mohit. Great to be here.

Mohit Bansal
Citigroup Inc. Exchange Research - Research Analyst

Great. And those who are listening to us today, if you have any questions, please feel free to e-mail me or send your questions via the webcast, and I'll be happy to just ask that for you anonymously.

So with that, Arvind, over to you, just wanted to give you an opportunity to give a brief overview

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot